Atara Biotherapeutics, Inc. / Fundamental strength relative to industry (Mohanram G-Value)

    The G-Value, developed by Mohanram in 2005, is a measure of a fundamental strength for growth companies. According to Mohanram, a low G-Value suggests a higher probability that a stock may be overvalued relative to its growth potential due to hype or overexcitement. The approach is described in detail in Mohanram's 2005 Paper Separating Winners from Losers among LowBook-to-Market Stocks using Financial Statement Analysis.

    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7
    Return on assets (ROA) greater than industry median
    check 15.7% > -50.3%
    Operating cash flow over total assets greater than industry median
    close -173.2% ≤ -42.3%
    Operating cash flow greater than net income
    close -$54.72M ≤ $4.96M
    Variance in ROA over the last 5 years less than industry median
    close 2,548.4% ≥ 3.5%
    Variance in year-over-year sales growth over the last 5 years less than industry median
    close 1,333.7% ≥ 36.1%
    R&D expenses over total assets greater than industry median
    check 291.0% > 39.5%
    Capex over total assets greater than industry median
    check 0.2% > 0.2%

    G-Value history

    The G-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the G-Value at a specific time in the past.

    3
    2
    2
    3
    2
    2
    3
    3
    2
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    3
    4
    4
    3
    4
    3
    3
    3
    3
    3
    2
    3
    2
    3
    3
    3

    Notifications